This review focuses mainly on PCT and CRP, since they are the most studied and most used biomarkers in daily clinical practice in the management of patients with pneumonia, given their clinical utility, low cost, and easy availability elsewhere. This evidence concerns the gene CALCA and susceptibility to pneumonia measurement.